NOT-AA-20-025: Notice of Extension of the Expiration Date for PAR-18-578 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44

Notice of Extension of the Expiration Date for PAR-18-578 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)"

Notice Number:

NOT-AA-20-025

Key Dates

Release Date:

December 9, 2020

Related Announcements

PAR-18-578 - Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)

Issued by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-18-578 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)" for one receipt cycle.

Due to the extension, the following dates will be added:

Application due date : March 25, 2021.
Scientific Merit Review: July 2021
Advisory Council: October 2021

Current Expiration Date: December 5, 2020.

New Expiration Date: March 26, 2021.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Raye Z. Litten, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-0636
Email: [email protected]